JPRN-UMIN000010201已完成2 期
Multicenter study of cisplatin-based chemotherapy with short hydration for lung cancer patients - Multicenter study of cisplatin-based chemotherapy with short hydration for lung cancer patients
ippon Medical School Hospital0 个研究点目标入组 45 人开始时间: 2013年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 74years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Comorbidity (congestive heart failure, angina, myocardial infarction) 2. Pleural effusion, pericardial effusion, ascites, brain metastases, bone metastases which needs intervention 3. Active infection 4. Steroid treatment
研究者
相似试验
已完成
2 期
Multicenter randomized phase II study of cisplatin+pemetrexed+bevacizmab followed by maintenance pemetrexied with or without bevacizmab in patients chemoterapy-naive advanced non-squamous non-small cell lung cancer with wild type EGFR(TORG1321)JPRN-UMIN000010681Thoracic Oncology Tesearch Group108
已完成
不适用
Feasibility study of cisplatin-based chemotherapy with short hydration for lung cancer patientsung cancerJPRN-UMIN000004727ational Cancer Center Hospital44
进行中（未招募）
2 期
Phase II Study of Cisplatin, Gemcitabine, and Necitumumab in Patients with Unresectable, Advanced or Recurrent Squamous Cell Carcinoma of the Lung after Combination of Immunotherapy and Chemotherapy.Squamous cell carcinomaon-small-cell lung cancerJPRN-jRCTs051200138Yoshioka Hiroshige45
尚未招募
Unknown
A study to evaluate cisplatin induced hearing loss among patients of head and neck cancers receiving chemoradiation treatmentCTRI/2024/08/072465Sri Venkateshwara Institute of medical sciences
已完成
4 期
A multicentre study using the chemotherapy combination of bi-monthly Xeloda and Eloxatin, with the addition of Avastin, in patients with advanced colorectal cancerCancerColorectal cancerISRCTN41540878Cancer Trials New Zealand (CTNZ)60